Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Prescription Drugs & Other Medical Products

Reports

Displaying 31 - 40 of 125. 10 per page. Page 4.

Advanced Search
Report to Congress

Report to Congress: Prescription Drugs: Innovation, Spending, and Patient Access

September 25, 2019
This Report responded to a request from the House and Senate Committees on Appropriations.
Report to Congress

Report to Congress: Prescription Drug Pricing Report

September 25, 2019
The Secretary of Health and Human Services (HHS) has been directed to submit a drug pricing report containing information requested by the House Committee on Appropriations.

Non-Fatal Opioid Overdose and Associated Health Outcomes: Final Summary Report

September 3, 2019
Non-fatal opioid overdose (NFOO) is a significant cause of opioid-related morbidity in the United States. As the number of NFOOs continues to grow, it is important to understand the short- and long-term consequences of NFOO.
Report

Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions

July 7, 2019
The purpose of this report is to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.

Psychosocial Supports in Medication-Assisted Treatment: Recent Evidence and Current Practice

July 7, 2019
ABSTRACT This report was included as Appendix B of "Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions." That report's purpose was to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.
ASPE Issue Brief

Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief

July 7, 2019
Westat Printer Friendly Version in PDF Format (3 PDF pages)
ASPE Issue Brief

Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief

July 2, 2019
As the opioid epidemic has evolved into a national crisis, the need for treatment has increased greatly. Medication-assisted treatment (MAT) is a “whole-patient” approach to the treatment of opioid use disorder (OUD) that combines the use of medications and psychosocial supports, such as therapy, counseling, self-help groups, and case management.

Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions

July 2, 2019
July 2019 Printer Friendly Version in PDF Format (47 PDF pages)

Choice Matters: Housing Models that May Promote Recovery for Individuals and Families Facing Opioid Use Disorder

June 23, 2019
The purpose of the Opioid Use Disorder, Housing Instability and Housing Options for Recovery project was to help ASPE and HUD describe the housing models available for individuals with Opioid Use Disorder (OUD) who experience housing instability or homelessness.

Choices Matter: Housing Models that May Promote Recovery for Individuals and Families Facing Opioid Use Disorder

June 23, 2019
ASPE recently completed a research project, conducted by Abt Associates, that explored homelessness and opioid use disorder, along with the evidence base for different models for care. This brief is highlights of findings from the project.